Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: CAS:1210-07-7 (
C14H11NO
)
2
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The efficiency of a recently proposed novel global optimization method, energy landscape paving (ELP), is evaluated with regard to the problem of crystal structure determination from simulated X-ray diffraction data comprising integrated diffraction intensities. The new approach has been tested using the example of 9-(methylamino)-1H-phenalen-1-one 1,4-dioxan-2-y1 hydroperoxide solvate (
C14H11NO
.C4H8O4). The results indicate that, for this example, ELP outperforms standard techniques such as simulated annealing.
...
PMID:Energy landscape paving for X-ray structure determination of organic molecules. 1196 Dec 87
Three 1-phenylindolin-2-one derivatives, namely 1-phenylindolin-2-one,
C14H11NO
, (I), 5-bromo-1-phenylindolin-2-one, C14H10BrNO, (II), and 5-iodo-1-phenylindolin-2-one, C14H10INO, (III), have been synthesized and their structures determined. Compounds (I) and (II) crystallized in the centrosymmetric space groups Pbca and P21/c, respectively, while compound (III) crystallized in the polar space group Aea2. Density functional theory (DFT) calculations show that the molecular dipole moment gradually decreases in the order (I) > (II) > (III). The relatively smaller dipole moment of (III) and the larger non-electrostatic intermolecular interactions may be the main reasons for the noncentrosymmetric and polar structure of (III).
...
PMID:Three 1-phenylindolin-2-one derivatives displaying different molecular dipole moments and different crystallographic symmetries. 2556 79